Skip to main content

Improving patient outcomes with innovative diagnostics for
critical care: Actionable insights in real-time

Discover our Biomarker Solutions

The Biomarker Company

SphingoTec develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary blood-based protein biomarkers for the diagnosis, outcome prediction, and monitoring of critical medical conditions, such as sepsis, acute heart failure, circulatory failure and acute kidney injury.

SphingoTec’s first-in-class biomarker tests are made available on its proprietary whole-blood point-of-care Nexus IB10 platform for convenient and rapid testing in near-patient and laboratory settings alongside a broad portfolio of standard-of-care test for critical care. For high-throughput testing in central laboratories, SphingoTec partners with global IVD players. 

EU & US BASED

SphingoTec is headquartered near Berlin, Germany while its wholly owned subsidiary Nexus Dx is based in San Diego, CA, USA.

IP PROTECTION

All of SphingoTec's biomarkers are globally patent protected

COMMERCIAL PLATFORM

Diagnostic assays for SphingoTec‘s biomarkers are available on its proprietary fully developed and commercialized  POC platform Nexus IB10

CLINICAL DEVELOPMENT

SphingoTec’s biomarkers are broadly validated and published in peer-reviewed journals

DIAGNOSTIC SOLUTIONS

In collaboration with an international network of key opinion leaders, SphingoTec develops solutions for fighting mortality in critical care conditions

KNOW-HOW

SphingoTec’s management builds on an extraordinary track-record in R&D and commercialization of novel diagnostic solutions

Innovative acute care biomarkers

Following a deep understanding of disease biology, SphingoTec developes novel biomarkers addressing diagnostically underserved critical care conditions such sepsis, acute heart failure, acute kidney injury, and cardiogenic shock

Discover more

Point-of-care testing with Nexus IB10 Analyzer

The CE-IVD marked Nexus IB10 platform is a fully automated rapid immunoassay point-of-care instrument. With a hands-on-time of less than 3 minutes the easy-to-use system provides in only 20 minutes test results for biomarkers that are crucial in the management of critical care patients.

Discover more


Diagnostic solutions

Sepsis

Diagnostic tools in Sepsis

Recent research has identified new molecules that are informative and help clinicians understand the etiology of the patient’s clinical symptoms, paving the way for personalized medicine in the field of sepsis.

COVID-19

Diagnostic tools in COVID-19 

The global COVID-19 pandemic has challenged health systems world-wide, with about 5% of patients requiring admission to intensive care units (ICU). Read more on the relevance of novel and established biomarker SphingoTec assays in the management of the critically ill COVID-19 patients.

Latest News

16. December 2020
SphingoTec GmbH (“SphingoTec”) announced today that the Acute Disease Quality Initiative (ADQI) recommends the use of novel biomarkers for AKI, including functional biomarkers as penKid®.
Read more
10. December 2020

The Uniklinik RWTH Aachen (“Uniklinik RWTH Aachen”) has successfully translated the collaboration for research and biomarker validation with SphingoTec GmbH (“SphingoTec”) into clinical routine. 

Read more
29. September 2020

BHR Pharmaceuticals Ltd (“BHR”) and SphingoTec GmbH (“SphingoTec”) today announced that they have signed a distribution agreement for the commercialization of SphingoTec’s portfolio of diagnostics solutions in acute and critical care in UK and Ireland. 

Read more

Events & Expos

14. - 17. June 2021

11:00 - 20:00

tba

BI0 international convention brings together biotech and pharma leaders to share insights and together develop the foundations of future solutions. 

Read more
16. - 19. March 2021

11:00 - 20:00

Brussels, Belgium

2021 year is the 40th edition of the ISICEM congress in Brussels and we are delighted to once again be exhibiting. 

Read more
20. - 22. January 2021

08:27 - 08:30

virtual

The Forum Interdisciplinary Intensive Care Medicine is an advanced training event for medical leaders.

Read more

Subscribe to our Newsletter

Follow the link below to subscribe to our Newsletter & receive updates on our company and products

Subscribe now

Follow our Journey on Social Media